advertisement
11.15 Other drugs in relation to glaucoma (24)
Showing records 1 to 24
Display all abstracts in classification 11.15 Other drugs in relation to glaucoma
Search within classification 11.15 Other drugs in relation to glaucoma58772 Renin-angiotensin system regulates neurodegeneration in a mouse model of normal tension glaucoma
Semba K; Namekata K; Guo X; Harada C; Harada T; Mitamura Y
Cell Death and Disease 2014; 5: e1333
58864 Short-term intraocular pressure trends following intravitreal ranibizumab injections for neovascular age-related macular degeneration-the role of oral acetazolamide in protecting glaucoma patients
Murray CD; Wood D; Allgar V; Walters G; Gale RP
Eye 2014; 28: 1218-1222
59359 Ocular Hypertension Following Intravitreal Antivascular Endothelial Growth Factor Therapy: Review of the Literature and Possible Role of Nitric Oxide
Morshedi RG; Ricca AM; Wirostko BM
Journal of Glaucoma 2016; 25: 291-300
58854 Acute transient myopia with shallowing of the anterior chamber induced by sulfamethoxazole in a patient with pseudoxanthoma elasticum
Araújo JR; Silva SE; Cruz F; Falcão-Reis F
Journal of Glaucoma 2014; 23: 415-417
58855 IMPACT ON INTRAOCULAR PRESSURE AFTER 20-MG DECANTED TRIAMCINOLONE ACETONIDE (KENALOG) INJECTION WHEN USING PROPHYLACTIC ANTIGLAUCOMA THERAPY
Barteselli G; Amini P; Ezon IC; Nezgoda JT; Cheng L; Freeman WR
Retina (Philadelphia, Pa.) 2015; 35: 75-81
59425 Intravitreal bevacizumab and Ahmed glaucoma valve implantation in patients with neovascular glaucoma
Zhang HT; Yang YX; Xu YY; Yang RM; Wang BJ; Hu JX
International Journal of Ophthalmology 2014; 7: 837-842
58776 Prophylactic use of bevacizumab to avoid anterior segment neovascularization following proton therapy for uveal melanoma
Mantel I; Schalenbourg A; Bergin C; Petrovic A; Weber DC; Zografos L
American Journal of Ophthalmology 2014; 158: 693-701.e2
58727 Efficacy and safety of intravitreal bevacizumab in eyes with neovascular glaucoma undergoing ahmed glaucoma valve implantation: 2-year follow-up
Arcieri ES; Paula JS; Jorge R; Barella KA; Arcieri RS; Secches DJ; Costa VP
Acta Ophthalmologica 2015; 93: e1-e6
59517 Surgical Treatment of Neovascular Glaucoma
Fili S; Kohlhaas M; Schilling H; Ligges U; Zelo I
Klinische Monatsblätter für Augenheilkunde 2014; 231: 1230-1238
59327 The influence of VEGF inhibitors on corneal endothelium after injection into the anterior chamber in a porcine eye model
Wilhelm A; Sietmann R; Wilhelm U; Hammer T
Ophthalmologe 2015; 112: 346-352
59325 Intravitreal Ranibizumab as Palliative Therapy for Iris Metastasis Complicated With Refractory Secondary Glaucoma
Makri OE; Psachoulia C; Exarchou A; Georgakopoulos CD
Journal of Glaucoma 2016; 25: e53-e55
58793 The effect of oral propranolol on intraocular pressure in infants with Sturge-Weber syndrome glaucoma
Wygnanski-Jaffe T; Spierer A; Melamed S; Ben-Zion I
European Journal of Ophthalmology 2014; 0: 0
58889 Immediate effect of intravitreal injection of bevacizumab on intraocular pressure
Lemos-Reis R; Moreira-Gonçalves N; Melo AB; Carneiro AM; Falcão-Reis FM
Clinical Ophthalmology 2014; 8: 1383-1388
59565 Ophthalmic patients on antithrombotic drugs: a review and guide to perioperative management
Kong KL; Khan J
British Journal of Ophthalmology 2015; 99: 1025-1030
58893 Safety of topiramate for treating migraines
Marmura MJ
Expert Opinion on Drug Safety 2014; 13: 1241-1247
59568 Cognitive Impairment and Age-Related Vision Disorders: Their Possible Relationship and the Evaluation of the Use of Aspirin and Statins in a 65 Years-and-Over Sardinian Population
Mandas A; Mereu RM; Catte O; Saba A; Serchisu L; Costaggiu D; Peiretti E; Caminiti G; Vinci M; Casu M; Piludu S; Fossarello M; Manconi PE; Dessí S
Frontiers in aging neuroscience 2014; 6: 309
58737 Effect of pegaptanib sodium 0.3 mg intravitreal injections (Macugen) in intraocular pressure: posthoc analysis from V.I.S.I.O.N. study
Boyer DS; Goldbaum M; Leys AM; Starita C;
British Journal of Ophthalmology 2014; 98: 1543-1546
58862 Intraocular pressure changes related to intravitreal injections of ranibizumab: analysis of pseudophakia and glaucoma subgroup
Demirel S; Yanik O; Batioglu F; Ozmert E
International Ophthalmology 2015; 35: 541-547
58976 Effects of ranibizumab on the extracellular matrix production by human Tenon's fibroblast
Md Noh SM; Sheikh Abdul Kadir SH; Bannur ZM; Froemming GA; Abdul Hamid Hasani N; Mohd Nawawi H; Crowston JG; Vasudevan S
Experimental Eye Research 2014; 127: 236-242
59154 Anti-inflammatory Therapy after Selective Laser Trabeculoplasty: A Randomized, Double-Masked, Placebo-Controlled Clinical Trial
Jinapriya D; D'Souza M; Hollands H; El-Defrawy SR; Irrcher I; Smallman D; Farmer JP; Cheung J; Urton T; Day A; Sun X; Campbell RJ
Ophthalmology 2014; 121: 2356-2361
59165 Subconjunctival bevacizumab to augment trabeculectomy with mitomycin C in the management of failed glaucoma surgery
Saeed AM; AboulNasr TT
Clinical Ophthalmology 2014; 8: 1745-1755
59513 Efficacy of Adjunctive Subconjunctival Bevacizumab on the Outcomes of Primary Trabeculectomy With Mitomycin C: A Prospective Randomized Placebo-controlled Trial
Kiddee W; Orapiriyakul L; Kittigoonpaisan K; Tantisarasart T; Wangsupadilok B
Journal of Glaucoma 2015; 24: 600-606
59593 Comparison study on the efficacy and safety of bevacizumab versus mitomycin C as adjuvants in trabeculectomy
Martín Giral E; Rivera Zori M; Perucho Martínez S; Toledano Fernández N
Archivos de la Sociedad Española de Oftalmologia 2015; 90: 63-68
58758 Ranibizumab Versus Mitomycin C in Primary Trabeculectomy - A Pilot Study
Pro MJ; Freidl KB; Neylan CJ; Sawchyn AK; Wizov SS; Moster MR
Current Eye Research 2014; 0: 1-6
